Redox proteomics identification of oxidatively modified myocardial proteins in human heart failure: Implications for protein function

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Brioschi, Maura ^a   Polvani, Gianluca ^a,b   Fratto, Pasquale ^c   Parolari, Alessandro ^a,b   Agostoni, Piergiuseppe ^a,b,d   Tremoli, Elena ^a,b   Banfi, Cristina ^a  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN II; MITOCHONDRIAL CREATINE KINASE; NORADRENALIN; REACTIVE OXYGEN METABOLITE; CREATINE KINASE MM; MUSCLE PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME REPRESSION; FEMALE; FUNCTIONAL PROTEOMICS; HEART FAILURE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; MALE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN OXIDATION; CASE CONTROL STUDY; CHEMISTRY; HEART MUSCLE; HEART MUSCLE CELL; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEOMICS;

ADULT; CASE-CONTROL STUDIES; CREATINE KINASE, MM FORM; ENERGY METABOLISM; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MUSCLE PROTEINS; MYOCARDIUM; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEOMICS; REACTIVE OXYGEN SPECIES;

EID: 84860991695     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035841     Document Type: Article

References (60)

1. Giordano FJ, (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115: 500-508.
2. Mallat Z, Philip I, Lebret M, Chatel D, Maclouf J, et al. (1998) Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97: 1536-1539.
3. Sobotka PA, Brottman MD, Weitz Z, Birnbaum AJ, Skosey JL, et al. (1993) Elevated breath pentane in heart failure reduced by free radical scavenger. Free Radic Biol Med 14: 643-647.
4. Nakamura K, Kusano KF, Matsubara H, Nakamura Y, Miura A, et al. (2005) Relationship between oxidative stress and systolic dysfunction in patients with hypertrophic cardiomyopathy. J Card Fail 11: 117-123.
5. Dhalla AK, Hill MF, Singal PK, (1996) Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 28: 506-514.
6. Sam F, Kerstetter DL, Pimental DR, Mulukutla S, Tabaee A, et al. (2005) Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J Card Fail 11: 473-480.
7. Sawyer DB, Siwik, DA, Xiao L, Pimentel DR, Singh K, et al. (2002) Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 34: 379-388.
8. Heymes C, Bendall, JK, Ratajczak P, Cave AC, Samuel JL, et al. (2003) Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 41: 2164-2171.
9. Xu X, Hu X, Lu Z, Zhang P, Zhao L, et al. (2008) Xanthine oxidase inhibition with febuxostat attenuates systolic overload-induced left ventricular hypertrophy and dysfunction in mice. J Card Fail 14: 746-753.
10. Zhang P, Xu X, Hu X, van Deel ED, Zhu G, et al. (2007) Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Circ Res 100: 1089-1098.
11. Takimoto E, Champion HC, Li M, Ren S, Rodriguez ER, et al. (2005) Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest 115: 1221-1231.
12. Lu Z, Xu X, Hu X, Zhu G, Zhang P, et al. (2008) Extracellular superoxide dismutase deficiency exacerbates pressure overload-induced left ventricular hypertrophy and dysfunction. Hypertension 51: 19-25.
13. Rabilloud T, Chevallet M, Luche S, Leize-Wagner E, (2005) Oxidative stress response: a proteomic view. Expert Rev Proteomics 2: 949-956.
14. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R, (2003) Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329: 23-38.
15. Levine RL, Williams JA, Stadtman ER, Shacter E, (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233: 346-357.
16. Berlett BS, Stadtman ER, (1997) Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272: 20313-20316.
17. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
18. Banfi C, Brioschi M, Barcella S, Veglia F, Biglioli P, et al. (2008) Oxidized proteins in plasma of patients with heart failure: role in endothelial damage. Eur J Heart Fail 10: 244-251.
19. Banfi C, Brioschi M, Wait R, Begum S, Gianazza E, et al. (2005) Proteome of endothelial cell-derived procoagulant microparticles. Proteomics 5: 4443-4455.
20. White SM, Constantin PE, Claycomb WC, (2004) Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am J Physiol Heart Circ Physiol 286: H823-829.
21. Smith MA, Sayre LM, Anderson VE, Harris PL, Beal MF, et al. (1998) Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine. J Histochem Cytochem 46: 731-735.
22. Jaffrey SR, Snyder SH, (2001) The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE 86: L1.
23. Pantke U, Volk T, Schmutzler M, Kox W J, Sitte N, et al. (1999) Oxidized proteins as a marker of oxidative stress during coronary heart surgery. Free Radic Biol Med 27: 1080-1086.
24. Griffiths HR, (2000) Antioxidants and protein oxidation. Free Radic Res 33: 47-58.
25. Lokuta AJ, Maertz NA, Meethal SV, Potter KT, Kamp TJ, et al. (2005) Increased nitration of sarcoplasmic reticulum Ca2+-ATPase in human heart failure. Circulation 111: 988-995.
26. Butterfield DA, Hensley K, Cole P, Subramaniam R, Aksenov M, et al. (1997) Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease. J Neurochem 68: 2451-2457.
27. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL, (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320: 915-924.
28. Wyss M, Kaddurah-Daouk R, (2000) Creatine and creatinine metabolism. Physiol Rev 80: 1107-1113.
29. Wallimann T, Eppenberger HM, (1985) Localization and function of M-line-bound creatine kinase M-band model and creatine phosphate shuttle. Cell Muscle Motil 6: 239-285.
30. Ventura-Clapier R, Veksler V, Hoerter JA, (1994) Myofibrillar creatine kinase and cardiac contraction. Mol Cell Biochem 133: 125-144.
31. Nascimben L, Ingwall JS, Pauletto P, Friedrich J, Gwathmey JK, et al. (1996) Creatine kinase system in failing and nonfailing human myocardium. Circulation 94: 1894-1901.
32. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, et al. (1997) Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96: 2190-2196.
33. Mihm MJ, Coyle CM, Schanbacher BL, Weinstein DM, Bauer JA, (2001) Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc Res 49: 798-807.
34. Koufen P, Stark G, (2000) Free radical induced inactivation of creatine kinase: sites of interaction, protection, and recovery. Biochim Biophys Acta 1501: 44-50.
35. Thomas C, Carr AC, Winterbourn CC, (1994) Free radical inactivation of rabbit muscle creatinine kinase: catalysis by physiological and hydrolyzed ICRF-187 (ICRF-198) iron chelates. Free Radic Res 21: 387-397.
36. Wood TD, Guan Z, Borders CL, Chen LH, Kenyon GL, et al. (1998) Creatine kinase: essential arginine residues at the nucleotide binding site identified by chemical modification and high-resolution tandem mass spectrometry. Proc Natl Acad Sci U S A 95: 3362-3365.
37. Aksenov M, Aksenova M, Butterfield DA, Markesbery WR, (2000) Oxidative modification of creatine kinase BB in Alzheimer's disease brain. J Neurochem 74: 2520-2527.
38. Barreiro E, Gea J, Matar G, Hussain SN, (2005) Expression and carbonylation of creatine kinase in the quadriceps femoris muscles of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 36: 636-642.
39. Schulman IH, Hare JM, (2011) Regulation of cardiovascular cellular processes by S-nitrosylation. Biochim Biophys Acta Apr 16 epub.
40. Sun J, Murphy E, (2010) Protein S-nitrosylation and cardioprotection. Circ Res 106: 285-296.
41. Decking UK, Williams JP, Dahmann R, Stumpe T, Kelm M, et al. (2001) The nitric oxide-induced reduction in cardiac energy supply is not due to inhibition of creatine kinase. Cardiovasc Res 51: 313-321.
42. Gonzalez DR, Treuer AV, Castellanos J, Dulce RA, Hare JM, (2010) Impaired S-nitrosylation of the ryanodine receptor caused by xanthine oxidase activity contributes to calcium leak in heart failure. J Biol Chem 285: 28938-28945.
43. Canton M, Menazza S, Sheeran FL, Polverino de Laureto P, et al. (2011) Oxidation of myofibrillar proteins in human heart failure. J Am Coll Cardiol 57: 300-309.
44. Rappaport L, Samuel JL, Bertier B, Bugaisky L, Marotte F, et al. (1984) Isomyosins, microtubules and desmin during the onset of cardiac hypertrophy in the rat. Eur Heart J 5: 243-250.
45. Schaper J, Froede R, Hein S, Buck A, Hashizume H, et al. (1991) Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 83: 504-514.
46. Missov E, Calzolari C, Pau B, (1997) Circulating cardiac troponin I in severe congestive heart failure. Circulation 96: 2953-2958.
47. Dalle-Donne I, Rossi R, Giustarini D, Gagliano N, Lusini L, et al. (2001) Actin carbonylation: from a simple marker of protein oxidation to relevant signs of severe functional impairment. Free Radic Biol Med 31: 1075-1083.
48. Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, Markesbery WR, (2001) Protein oxidation in the brain in Alzheimer's disease. Neuroscience 103: 373-383.
49. O'Reilly PJ, Hickman-Davis JM, Davis IC, Matalon S, (2003) Hyperoxia impairs antibacterial function of macrophages through effects on actin. Am J Respir Cell Mol Biol 28: 443-450.
50. Oh-Ishi M, Ueno T, Maeda T, (2003) Proteomic method detects oxidatively induced protein carbonyls in muscles of a diabetes model Otsuka Long-Evans Tokushima Fatty (OLETF) rat. Free Radic Biol Med 34: 11-22.
51. Banan, A, Zhang Y, Losurdo J, Keshavarzian A, (2000) Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line. Gut 46: 830-837.
52. Keshavarzian A, Banan A, Farhadi A, Komanduri S, Mutlu E, et al. (2003) Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 52: 720-728.
53. Canton M, Neverova I, Menabò R, Van Eyk J, Di Lisa F, (2004) Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts. Am J Physiol Heart Circ Physiol 286: H870-877.
54. Aldini G, Dalle-Donne I, Vistoli G, Maffei Facino R, Carini M, (2005) Covalent modification of actin by 4-hydroxy-trans-2-nonenal (HNE): LC-ESI-MS/MS evidence for Cys374 Michael adduction. J Mass Spectrom 40: 946-954.
55. Gayarre J, Sánchez D, Sánchez-Gómez FJ, Terrón MC, Llorca O, et al. (2006) Addition of electrophilic lipids to actin alters filament structure. Biochem Biophys Res Commun 349: 1387-1393.
56. Linares M, Marin-Garcia P, Mendez D, Puyet A, Diez A, et al. (2011) Proteomic approaches to identifying carbonylated proteins in brain tissue. J Proteome Res 10: 1719-1727.
57. Grimsrud PA, Xie H, Griffin TJ, Bernlohr DA, (2008) Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem 283: 21837-21841.
58. Ahmed Z, Tang WH, (2012) Pharmacologic Strategies to Target Oxidative Stress in Heart Failure. Curr Heart Fail Rep Jan 3 epub.
59. Nasr G, Maurice C, (2010) Allopurinol and global left myocardial function in heart failure patients. J Cardiovasc Dis Res 1: 191-195.
60. Gerszten RE, Accurso F, Bernard GR, Caprioli RM, Klee EW, et al. (2008) Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs. Am J Physiol Lung Cell Mol Physiol 295: L16-22.